NCT00192075 A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00191568 Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00186277 Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT00184028 Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck Status TERMINATED Phase PHASE2
NCT00182715 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00177307 Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00159432 Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00156975 Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases Status UNKNOWN Phase PHASE3
NCT00154791 Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00142480 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00142467 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00138177 Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00129870 CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer Status TERMINATED Phase PHASE4
NCT00126256 Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00125034 Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT00123851 Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00118755 A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00118261 Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00118105 S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Status WITHDRAWN Phase PHASE2